… Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a
range of 13.5% in Africa and 31.8% in the Middle East. Nonalcoholic fatty liver disease is …

… who underwent liver transplantation for NASH or nonalcoholic fatty liver disease (NAFLD).
All … of patients with or without NASH after liver transplantation were considered. Odds ratios (…

… or de novo nonalcoholic fatty liver disease after liver transplantation: … Nonalcoholic fatty liver
disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. …

… We assessed liver transplant listing trends by CLD etiology. … of Transplant Recipients (2002
through 2019), we found NASH to be the second most common indication for liver transplant …

… cause of chronic liver disease (CLD), has a global prevalence of 25%. Its progressive form,
nonalcoholic steatohepatitis (NASH), is a leading indication for liver transplantation (LT) in …

… Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults
awaiting liver transplantation in … of liver transplantation for nonalcoholic steatohepatitis in the …

… Little is known about outcomes of liver transplantation for patients with non-alcoholic
steatohepatitis (NASH). We aimed to determine the frequency and outcomes of liver transplantation …

… Non-alcoholic steatohepatitis is a growing liver-related health problem. In Europe, non-alcoholic
fatty liver disease is the most usual reason of chronic liver illness while steatohepatitis, …

… liver transplantation for nonalcoholic steatohepatitis (NASH) … as an indication for liver
transplantation increased 5-fold over … Nonalcoholic fatty liver disease describes a spectrum of liver …

… orthotopic liver transplantation (LT) addressing NAFLD and NASH as causes of end-stage
liver disease requiring LT, the evaluation of NAFLD/NASH patients for LT, the use of steatotic …